┌──────────────────────────────────────────────────────────────┐ RECORD TYPE ......... SUBJECT FILE SUBJECT TYPE ........ PERSON FILE OPENED ......... 2026-07-05 17:21 UTC APPEARANCES ......... 3 ANNOTATIONS KNOWN ALIASES ....... 1 └──────────────────────────────────────────────────────────────┘
Martin Keller
ALSO APPEARS AS
- Martin Keller
APPEARS IN THE MARGINS OF
- Study 329: Paroxetine Clinical Trial Data Suppression and Publication Bias
Study 329 was an eight-week, placebo-controlled, double-blind randomized clinical trial of paroxetine (Paxil/Seroxat) in adolescents with depression, conducted in the late 1990s and published in 2001.…
- GSK Contractual Restrictions on Paroxetine Research Publication
This investigation concerns whether GlaxoSmithKline (GSK) contractually restricted Martin Keller's ability to publish findings unfavorable to the antidepressant paroxetine (marketed as Paxil/Seroxat),…
- GSK Paroxetine Trials: Publication Rights and Ghostwriting Agreements
This dossier investigates the availability of contractual agreements between GlaxoSmithKline (GSK) and individual researchers, such as Martin Keller, involved in paroxetine clinical trials, particular…